Cm Management, LLC Bio Cardia, Inc. Transaction History

Cm Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.37 - $1.07 $37,000 - $107,000	100,000 Added 16.67%	700,000 $462,000
Q3 2023 Nov 07, 2023	BUY	$0.37 - $2.85 $95,090 - $732,450	257,000 Added 74.93%	600,000 $258,000
Q2 2023 Aug 04, 2023	BUY	$1.52 - $2.8 $21,280 - $39,200	14,000 Added 4.26%	343,000 $916,000
Q2 2021 Aug 10, 2021	BUY	$48.9 - $74.85 $777,510 - $1.19 Million	15,900 Added 5.08%	329,000 $1.31 Million
Q1 2021 May 12, 2021	BUY	$51.3 - $78.15 $4.26 Million - $6.49 Million	83,100 Added 36.13%	313,100 $1.36 Million
Q4 2020 Feb 04, 2021	BUY	$28.8 - $100.5 $6.62 Million - $23.1 Million	230,000 New	230,000 $796,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.